CDC25A, VAV1, TP73, BRCA1 and ZAP70 gene overexpression correlates with radiation response in colorectal cancer

Oncology Reports

Volumn 25, Issue 5, 2011, Pages 1297-1306

  Huang, Ming Yii ^a,b   Wang, Jaw Yuan ^a,b   Chang, Hui Jen ^c,d   Kuo, Chia Wei ^b   Tok, Teck Siang ^e   Lin, Shiu Ru ^c,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

^e PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

BRCA1; CDC25A; Colorectal cancer; Membrane array; Microarray; Radiation response; TP73; VAV1; ZAP70

Indexed keywords

BRCA1 PROTEIN; CELL CYCLE PROTEIN; CELL DIVISION CYCLE 25 HOMOLOG A; PROTEIN KINASE ZAP 70; PROTEIN P73; UNCLASSIFIED DRUG; VAV 1 GUANINE NUCLEOTIDE EXCHANGE FACTOR; VAV PROTEIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNE RESPONSE; LYMPH NODE METASTASIS; MALE; PHOTON THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN MICROARRAY; RADIATION RESPONSE; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; UPREGULATION;

AGED; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; FEMALE; GAMMA RAYS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RADIATION TOLERANCE;

EID: 79953034310     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1193     Document Type: Article

References (52)

1. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish rectal cancer trial. N Engl J Med 336: 980-987, 1997.
2. Glimelius B, Gronberg H, Jarhult J, Wallgren A and Cavallin-Stahl E: A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 42: 476-492, 2003. (Pubitemid 37193839)
3. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 358: 1291-1304, 2001.
4. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, Eng C, Krishnan S, Janjan NA and Crane CH: Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109: 1750-1755, 2007. (Pubitemid 46668536)
5. Park HC, Janjan NA, Mendoza TR, Lin EH, Vadhan-Raj S, Hundal M, Zhang Y, Delclos ME, Crane CH, Das P, Wang XS, Cleeland CS and Krishnan S: Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 75: 775-781, 2009.
6. Kremser C, Trieb T, Rudisch A, Judmaier W and de Vries A: Dynamic T(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis. J Magn Reson Imaging 26: 662-671, 2007. (Pubitemid 350194589)
7. Konski A, Li T, Sigurdson E, Cohen SJ, Small W Jr, Spies S, Yu JQ, Wahl A, Stryker S and Meropol NJ: Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys 74: 55-59, 2009.
8. Jiang SM, Wang RB, Yu JM, Zhu KL, Mu DB and Xu ZF: [Correlation of VEGF and KI67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma]. Zhonghua Zhong Liu Za Zhi 30: 602-605, 2008.
9. Kuremsky JG, Tepper JE and McLeod HL: Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 74: 673-688, 2009.
10. Amundson SA, Do KT, Vinikoor LC, Lee RA, Koch-Paiz CA, Ahn J, Reimers M, Chen Y, Scudiero DA, Weinstein JN, Trent JM, Bittner ML, Meltzer PS and Fornace AJ Jr: Integrating global gene expression and radiation survival parameters across the 60 cell lines of the national cancer institute anticancer drug screen. Cancer Res 68: 415-424, 2008. (Pubitemid 351380067)
11. Correa CR and Cheung VG: Genetic variation in radiation-induced expression phenotypes. Am J Hum Genet 75: 885-890, 2004. (Pubitemid 39390496)
12. Lehnert S: Prediction of tumor response to therapy: molecular markers and the micro environment. Apoptosis and chips: an overview of the proceedings. Radiat Res 154: 121-124, 2000.
13. Wong YF, Sahota DS, Cheung TH, Lo KW Yim SF, Chung TK, Chang AM and Smith DI: Gene expression pattern associated with radiotherapy sensitivity in cervical cancer. Cancer J 12: 189-193, 2006. (Pubitemid 43894334)
14. Gillham CM, Reynolds J and Hollywood D: Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation. World J Surg Oncol 5: 97, 2007.
15. Ghadimi BM, Grade M, Difilippantonio MJ, Varma S, Simon R, Montagna C, Fuzesi L, Langer C, Becker H, Liersch T and Ried T: Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Qin Oncol 23: 1826-1838, 2005.
16. Watanabe T, Komuro Y, Kiyomatsu T, Kanazawa T, Kazama Y, Tanaka J, Tanaka T, Yamamoto Y, Shirane M, Muto T and Nagawa H: Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. Cancer Res 66: 3370-3374, 2006.
17. Dairkee SH, Ji Y, Ben Y, Moore DH, Meng Z and Jeffrey SS: A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue. BMC Genomics 5: 47, 2004.
18. Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radio sensitivity. Cancer Res 47: 943-946, 1987. (Pubitemid 17027906)
19. de la Monte SM, Lahousse SA, Carter J and Wands JR: ATP luminescence-based motility-invasion assay. Biotechniques 33: 98-100, 2002.
20. International Union Against Cancer. TNM classification of malignant tumors. 6th edition. Wiley-liss, New York, 2002.
21. Janku F, Srovnal J, Korinkova G, Novotny J, Petruzelka L, Power D, Matous B and Hajduch M: Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT-PCR for CEA. Neoplasma 55: 317-322, 2008.
22. Chen YF, Wang JY, Wu CH, Chen FM, Cheng TL and Lin SR: Detection of circulating cancer cells with K-ras oncogene using membrane array. Cancer Lett 229: 115-122, 2005.
23. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC and Lempicki RA: David: database for annotation, visualization, and integrated discovery. Genome Biol 4: 3, 2003.
24. Zhong H, Yang X, Kaplan LM, Molony C and Schadt EE: Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet 86: 581-591, 2010.
25. West CM, Davidson SE, Roberts SA and Hunter RD: The independence of intrinsic radio sensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer 76: 1184-1190, 1997. (Pubitemid 27448015)
26. Spitz FR, Gacco GG, Hess K, Larry L, Rich TA, Janjan N, Cleary KR and Skibber JM: p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer. Clin Cancer Res 3: 1685-1690, 1997. (Pubitemid 27444705)
27. Luna-Perez P, Arriola EL, Cuadra Y, Alvarado I and Quintero A: p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma. Ann Surg Oncol 5: 203-208, 1998. (Pubitemid 28249307)
28. Saw RP, Morgan M, Koorey D, Painter D, Findlay M, Stevens G, Clarke S, Chapuis P and Solomon MJ: p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy. Dis Colon Rectum 46: 192-202, 2003. (Pubitemid 36222619)
29. Tannapfel A, Nusslein S, Fietkau R, Katalinic A, Kockerling F and Wittekind C: Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radio chemotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 41: 585-591, 1998. (Pubitemid 28275088)
30. Kim NK, Park JK, Lee KY, Yang WI, Yun SH, Sung J and Min JS: p53, BCL-2, and KI-67 expression according to tumor response after concurrent chemo radiotherapy for advanced rectal cancer. Ann Surg Oncol 8: 418-424, 2001.
31. Sklar MD: The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 239: 645-647, 1988.
32. Kasid U, Pfeifer A, Weichselbaum RR, Dritschilo A and Mark GE: The raf oncogene is associated with a radiation-resistant human laryngeal cancer. Science 237: 1039-1041, 1987. (Pubitemid 17131202)
33. Rodel F, Hoffmann J, Distel L, Herrmann M, Noisternig T, Papadopoulos T, Sauer R and Rodel C: Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 65: 4881-4887, 2005. (Pubitemid 40740827)
34. Ojima E, Inoue Y, Miki C, Mori M and Kusunoki M: Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy. J Gastroenterol 42: 730-736, 2007. (Pubitemid 47456760)
35. Sinclair WK and Morton RA: X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat Res 29: 450-474, 1966.
36. Sinclair WK: Cyclic x-ray responses in mammalian cells in vitro. Radiat Res 33: 620-643, 1968.
37. Knoops L, Haas R, de Kemp S, Majoor D, Broeks A, Eldering E, de Boer JP, Verheij M, van Ostrom C, de Vries A, van't Veer L and de Jong D: In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma. Blood 110: 1116-1122, 2007.
38. Gasic GJ: Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Rev 3: 99-114, 1984.
39. Tohgo A, Tanaka NG and Ogawa H: Platelet-aggregating activities of metastasizing tumor cells. Iv. Effects of cell surface modification on thrombin generation, platelet aggregation and subsequent lung colonization. Invasion Metastasis 6: 58-68, 1986.
40. Rickles FR: Mechanisms of cancer-induced thrombosis in cancer. Pathophysiol Haemost Thromb 35: 103-110, 2006.
41. Ulrich D, Ulrich F, Silny J, Unglaub F and Pallua N: [Chiparray-based identification of gene expression in HUVECS treated with low frequency electric fields]. Handchir Mikrochir Plast Chir 38: 149-155, 2006.
42. Hernandez S, Hernandez L, Bea S, Cazorla M, Fernandez PL, Nadal A, Muntane J, Mallofre C, Montserrat E, Cardesa A and Campo E: Cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas. Cancer Res 58: 1762-1767, 1998. (Pubitemid 28215106)
43. Wu W, Fan YH, Kemp BL, Walsh G and Mao L: Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. Cancer Res 58: 4082-4085, 1998. (Pubitemid 28440560)
44. Nishioka K, Doki Y, Shiozaki H, Yamamoto H, Tamura S, Yasuda T, Fujiwara Y, Yano M, Miyata H, Kishi K, Nakagawa H, Shamma A and Monden M: Qinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus. Br J Cancer 85: 412-421, 2001. (Pubitemid 32747711)
45. Dixon D, Moyana T and King MJ: Elevated expression of the cdc25A protein phosphatase in colon cancer. Exp Cell Res 240: 236-243, 1998. (Pubitemid 28371104)
46. Galaktionov K, Chen X and Beach D: Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382: 511-517, 1996. (Pubitemid 26260686)
47. Coco Martin JM, Balkenende A, Verschoor T, Lallemand F and Michalides R: Cyclin D1 overexpression enhances radiation-induced apoptosis and radio sensitivity in a breast tumor cell line. Cancer Res 59: 1134-1140, 1999. (Pubitemid 29135977)
48. Miyata H, Doki Y, Shiozaki H, Inoue M, Yano M, Fujiwara Y, Yamamoto H, Nishioka K, Kishi K and Monden M: Cdc25b and p53 are independently implicated in radiation sensitivity for human esophageal cancers. Qin Cancer Res 6: 4859-4865, 2000. (Pubitemid 32110430)
49. Tannapfel A, Wasner M, Krause K, Geissler F, Katalinic A, Hauss J, Mossner J, Engeland K and Wittekind C: Expression of p73 and its relation to histopathology and prognosis in hepato-cellular carcinoma. J Natl Cancer Inst 91: 1154-1158, 1999. (Pubitemid 29330554)
50. Chen X, Arciero CA and Godwin AK: BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance. Expert Rev Anticancer Ther 6: 187-196, 2006. (Pubitemid 44192930)
51. Trojani A, Montillo M, Nichelatti M, Tedeschi A, Colombo C, Veronese S, Mura MA, Ricci F, Scarpati B, Colosimo A, Lodola M and Morra E: ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia. Cancer Biomark 6: 1-9, 2010.
52. Lane J, Martin TA, Mansel RE and Jiang WG: The expression and prognostic value of the guanine nucleotide exchange factors (GEFs) Trio, Vav1 and TIAM1- in human breast cancer. Int Semin Surg Oncol 5: 23, 2008.